1.
Dellinger, E.P., et al., Determinant-based classification of acute pancreatitis severity: an international
multidisciplinary consultation. Ann Surg, 2012. 256(6): p. 875-80.
2.
Tenner, S., et al., American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol, 2013. 108(9): p. 1400-15; 1416.
3.
Wittau, M., et al., Systematic review and meta-analysis of antibiotic prophylaxis in severe acute pancreatitis. Scand J Gastroenterol, 2011. 46(3): p. 261-70.
4.
Luiten, E.J., et al., Controlled clinical trial of selective decontamination for the treatment of severe
acute pancreatitis. Ann Surg, 1995. 222(1): p. 57-65.
5.
Besselink, M.G., et al., Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind,
placebo-controlled trial. Lancet, 2008. 371(9613): p. 651-9.
6.
Uehara, S., et al., Immune function in patients with acute pancreatitis. J Gastroenterol Hepatol, 2003. 18(4): p. 363-70.
7.
Yu, W.K., et al., Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase
of acute pancreatitis. Pancreatology, 2004. 4(3-4): p. 233-43.
8.
Sun, J.K., et al., Effects of early enteral nutrition on immune function of severe acute pancreatitis
patients. World J Gastroenterol, 2013. 19(6): p. 917-22.
9.
Wu, J., et al., The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter, single-blind,
randomized and controlled trial. Crit Care, 2013. 17(1): p. R8.
10.
Martin-Loeches, I., et al., The protective association of endogenous immunoglobulins against sepsis mortality
is restricted to patients with moderate organ failure. Ann Intensive Care, 2017. 7(1): p. 44.
11.
Wang, X., et al., Thymosin alpha 1 is associated with improved cellular immunity and reduced infection
rate in severe acute pancreatitis patients in a double-blind randomized control study. Inflammation, 2011. 34(3): p. 198-202.
12.
Banks, P.A., et al., Classification of acute pancreatitis--2012: revision of the Atlanta classification
and definitions by international consensus. Gut, 2013. 62(1): p. 102-11.
13.
Balthazar, E.J., Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology, 2002. 223(3): p. 603-13.
14.
Zhang, Z., Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med, 2016. 4(2): p. 30.
15.
Zhang, Z., Univariate description and bivariate statistical inference: the first step delving
into data. Ann Transl Med, 2016. 4(5): p. 91.
16.
Vege, S.S., et al., Initial Medical Treatment of Acute Pancreatitis: American Gastroenterological Association
Institute Technical Review. Gastroenterology, 2018. 154(4): p. 1103-1139.
17.
Working Group, I.A.P.A.P.A.A.P.G., IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology, 2013. 13(4 Suppl 2): p. e1-15.
18.
Yokoe, M., et al., Japanese guidelines for the management of acute pancreatitis: Japanese Guidelines
2015. J Hepatobiliary Pancreat Sci, 2015. 22(6): p. 405-32.
19.
Mandalia, A., E.J. Wamsteker, and M. DiMagno, Recent advances in understanding and managing acute pancreatitis. F1000Res, 2018. 7.
20.
Minkov, G.A., Y.P. Yovtchev, and K.S. Halacheva, Increased Circulating CD4+CD25+CD127low/neg Regulatory T-cells as a Prognostic Biomarker
in Acute Pancreatitis. Pancreas, 2017. 46(8): p. 1003-1010.
21.
Yang, N., et al., The effect of thymosin alpha1 for prevention of infection in patients with severe
acute pancreatitis. Expert Opin Biol Ther, 2018. 18(sup1): p. 53-60.
22.
Kylanpaa-Back, M.L., et al., Cellular markers of systemic inflammation and immune suppression in patients with
organ failure due to severe acute pancreatitis. Scand J Gastroenterol, 2001. 36(10): p. 1100-7.
23.
Zorio, V., et al., Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after
ICU discharge. Ann Intensive Care, 2017. 7(1): p. 80.